Delivery Order SPE2DB24D1021-SPE2DB25FEYLN
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Entecavir 0.5 mg, an antiviral medication used in hepatitis B treatment, with a contract ceiling value of $8,002.96. This competitively awarded, firm fixed-price delivery order was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside...
- The Defense Logistics Agency awarded a $1,286.63 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Entecavir 0.5 mg, an antiviral medication used to treat chronic hepatitis B. This firm fixed price contract, awarded on July 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and is scheduled for completion by July 31, 2025,...
- The Defense Logistics Agency awarded a $3,411.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Entecavir 0.5 mg, a pharmaceutical product used in the treatment of hepatitis B. This non-set-aside competitive award was issued on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,084.36 to AmerisourceBergen Drug Corp for 30 tablets of Entecavir 0.5 mg, an antiviral medication used to treat hepatitis B. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.28 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,337.46. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,771.29, is for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a medication used to treat chronic hepatitis B. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,978.40 and a period of performance ending on November 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,996.61 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement profile....
- The Defense Logistics Agency awarded a delivery order valued at $1,774.43 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count packages) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed under a non-set-aside designation. The award is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...